nefazodone has been researched along with Substance Withdrawal Syndrome in 13 studies
nefazodone: may be useful as an opiate adjunct
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nefazodone, which is an antidepressant with sedative properties, may attenuate symptoms of marijuana withdrawal." | 2.71 | Nefazodone decreases anxiety during marijuana withdrawal in humans. ( Foltin, RW; Haney, M; Hart, CL; Ward, AS, 2003) |
| "Maintenance treatment to prevent recurrences is recommended for chronic forms of major depressive disorder (MDD), but few studies have examined maintenance efficacy of antidepressants with chronic MDD." | 2.71 | Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. ( Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J, 2003) |
| "The management of the patient's withdrawal symptoms is described." | 1.31 | Pharmacokinetically induced benzodiazepine withdrawal. ( Ninan, PT, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ninan, PT | 1 |
| Haney, M | 2 |
| Hart, CL | 1 |
| Ward, AS | 1 |
| Foltin, RW | 1 |
| Gelenberg, AJ | 1 |
| Trivedi, MH | 1 |
| Rush, AJ | 1 |
| Thase, ME | 1 |
| Howland, R | 1 |
| Klein, DN | 1 |
| Kornstein, SG | 1 |
| Dunner, DL | 1 |
| Markowitz, JC | 1 |
| Hirschfeld, RM | 1 |
| Keitner, GI | 1 |
| Zajecka, J | 1 |
| Kocsis, JH | 1 |
| Russell, JM | 1 |
| Miller, I | 1 |
| Manber, R | 1 |
| Arnow, B | 1 |
| Rothbaum, B | 1 |
| Munsaka, M | 1 |
| Banks, P | 1 |
| Borian, FE | 1 |
| Keller, MB | 1 |
| Tamam, L | 1 |
| Ozpoyraz, N | 1 |
| Mischoulon, D | 1 |
| Opitz, G | 1 |
| Kelly, K | 1 |
| Fava, M | 1 |
| Rosenbaum, JF | 1 |
| Benazzi, F | 2 |
| Lauber, C | 1 |
| Markowitz, JS | 1 |
| Kotlyar, M | 1 |
| Golding, M | 1 |
| Brewer, ER | 1 |
| Carson, SW | 1 |
| Scharf, MB | 1 |
| McDannold, M | 1 |
| Zaretsky, N | 1 |
| Spinner, O | 1 |
| Stover, R | 1 |
| Berkowitz, DV | 1 |
| Conrad, C | 1 |
| Rajagopalan, M | 1 |
| Little, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Wayne Warrior CAnnabis Research and Education: Naturalistic Observation and Harm Reduction[NCT05386862] | 215 participants (Anticipated) | Interventional | 2022-05-25 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nefazodone and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Effects of smoked marijuana in healthy and HIV + marijuana smokers.
Topics: Bupropion; Dronabinol; Eating; HIV Seropositivity; Humans; Marijuana Smoking; Piperazines; Substance | 2002 |
3 trials available for nefazodone and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Nefazodone decreases anxiety during marijuana withdrawal in humans.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Arousal; Attention; Dose-Response Relations | 2003 |
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; C | 2003 |
Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Periodicity; Pipe | 1999 |
9 other studies available for nefazodone and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Pharmacokinetically induced benzodiazepine withdrawal.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Inter | 2001 |
Discontinuation symptoms associated with nefazodone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relations | 2003 |
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relations | 2004 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Ther | 1997 |
Nefazodone withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Phobic Disorders | 1998 |
Nefazodone withdrawal syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Piperazines; Substance Withdrawal S | 1999 |
Re: Nefazodone withdrawal symptoms.
Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Drug Therapy, Combination; Humans; Pipe | 1999 |
Possible nefazodone withdrawal syndrome.
Topics: Adult; Dizziness; Humans; Male; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Substa | 1999 |
Discontinuation symptoms with nefazodone.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Dr | 1999 |